Organon Co Stock In The News

OGN Stock  USD 14.89  0.16  1.09%   
Our overall analysis of Organon's news coverage and content from conventional and social sources shows investors' bearish mood towards Organon Co. The specific impact of Organon news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Organon's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Organon headlines in addition to utilizing other, more conventional financial analysis modules. Check out Organon Backtesting and Organon Hype Analysis.

Organon Today Top News and Investor Outlook

Yahoo News
Organon (OGN) Loses -9.91% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
https://finance.yahoo.com/news/organon-ogn-loses-9-91-133505256.html
 Bullish
Yahoo News
Organon to Report Third Quarter 2024 Results and Host Conference Call on October 31, 2024
https://finance.yahoo.com/news/organon-report-third-quarter-2024-113000719.html
 Bullish
Yahoo News
Organon Canada Promotes Geneviève Gauthi...
https://finance.yahoo.com/news/organon-canada-promotes-genevi-ve-120100549.html
 Bullish
Yahoo News
Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11
https://finance.yahoo.com/news/primary-endpoint-met-phase-3-100000390.html
 Bullish
Yahoo News
Organon Canada and the Alberta Women's H...
https://finance.yahoo.com/news/organon-canada-alberta-womens-health-135000266.html
 Bullish
Yahoo News
Are Options Traders Betting on a Big Move in Organon (OGN) Stock?
https://finance.yahoo.com/news/options-traders-betting-big-move-130500982.html
 Bullish
Yahoo News
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
https://finance.yahoo.com/news/organon-acquire-dermavant-including-innovative-113000568.html
 Neutral
Yahoo News
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
https://finance.yahoo.com/news/jp-morgan-shows-most-interest-174607225.html
 Bullish
Yahoo News
Should WisdomTree U.S. SmallCap Dividend ETF (DES) Be on Your Investing Radar?
https://finance.yahoo.com/news/wisdomtree-u-smallcap-dividend-etf-102002226.html
 Bullish
Yahoo News
Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
https://finance.yahoo.com/news/organon-lilly-expand-migraine-commercialization-113000823.html
 Neutral

Organon Co Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Organon and other traded companies coverage with news coverage. We help investors stay connected with Organon headlines for the 22nd of November to make an informed investment decision based on correlating the impacts of news items on Organon Stock performance. Please note that trading solely based on the Organon Co hype is not for everyone as timely availability and quick action are needed to avoid losses.
Organon's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Organon Co investors visualize upcoming and past events in order to time the market based on Organon Co noise-free hype analysis.
Organon stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Organon earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Organon that are available to investors today. That information is available publicly through Organon media outlets and privately through word of mouth or via Organon internal channels. However, regardless of the origin, that massive amount of Organon data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Organon news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Organon relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Organon's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Organon alpha.

Organon Largest EPS Surprises

Earnings surprises can significantly impact Organon's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-02-16
2022-12-310.90.81-0.0910 
2022-02-17
2021-12-311.241.370.1310 
2023-11-02
2023-09-301.060.87-0.1917 
2022-11-03
2022-09-301.091.320.2321 
2021-11-11
2021-09-301.441.670.2315 
2024-05-03
2024-03-310.971.220.2525 
View All Earnings Estimates

Organon Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Organon Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
Macroaxis News
20th of November 2024
Disposition of 42553 shares by Daniel Karp of Organon subject to Rule 16b-3
at MacroaxisInsider 
zacks News
15th of November 2024
Organon Co. Is a Trending Stock Facts to Know Before Betting on It
at zacks.com 
news
13th of November 2024
Versor Investments LP Grows Stock Holdings in Organon Co.
at thelincolnianonline.com 
Gurufocus Stories at Macroaxis
12th of November 2024
Organon Co Stock Price Down 3.48 percent on Nov 12
at gurufocus.com 
news
11th of November 2024
Disposition of 42553 shares by Daniel Karp of Organon subject to Rule 16b-3
at thelincolnianonline.com 
Simply Wall St News at Macroaxis
8th of November 2024
Income Investors Should Know That Organon Co. Goes Ex-Dividend Soon
at simplywall.st 
news
7th of November 2024
Origin Protocol Self Reported Market Cap Achieves 93.93 Million
at thelincolnianonline.com 
Macroaxis News
6th of November 2024
Disposition of 42553 shares by Daniel Karp of Organon subject to Rule 16b-3
at MacroaxisInsider 
businesswire News
5th of November 2024
Update on FDA Review of VTAMA Cream, 1 percent for the Treatment of Atopic Dermatitis in A...
at businesswire.com 
Yahoo News
1st of November 2024
Organon Third Quarter 2024 Earnings EPS US1.39
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
31st of October 2024
Organon Co Shares Up 5.61 percent on Oct 31
at gurufocus.com 
news
28th of October 2024
Organon Co. Short Interest Up 28.2 percent in October
at thelincolnianonline.com 

Organon Investors Sentiment

The influence of Organon's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Organon. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Organon's public news can be used to forecast risks associated with an investment in Organon. The trend in average sentiment can be used to explain how an investor holding Organon can time the market purely based on public headlines and social activities around Organon Co. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Organon's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Organon's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Organon's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Organon.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Organon in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Organon's short interest history, or implied volatility extrapolated from Organon options trading.
When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock:
Check out Organon Backtesting and Organon Hype Analysis.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.081
Dividend Share
1.12
Earnings Share
5.05
Revenue Per Share
24.984
Quarterly Revenue Growth
0.041
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.